Schedule 13G ownership disclosure

PEREGRINE PHARMACEUTICALS INC

Security class unavailable · CUSIP: 713661304

Event date: 2015-10-30

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
30,106,945
Percent of class
13.1000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001408408-15-000052
Form type
SC 13G/A
Filer
Eastern Capital LTD
CIK
CIK 1408408
Filed
Nov 02, 2015
Reporting period
Oct 30, 2015
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub